NGL Fine Chem Ltd.
| BSE: 524774 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE887E01022 |
| BSE 00:00 | 26 Oct | 2681.95 |
127.70 (5.00%) |
OPEN
2630.00 |
HIGH
2681.95 |
LOW
2573.60 |
| NSE 05:30 | 01 Jan | NGL Fine Chem Ltd |
| OPEN | 2630.00 |
| PREVIOUS CLOSE | 2554.25 |
| VOLUME | 1245 |
| 52-Week high | 3789.45 |
| 52-Week low | 800.00 |
| P/E | 25.13 |
| Mkt Cap.(Rs cr) | 1,657 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
NGL Fine Chem Ltd. (NGLFINECHEM) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 703.80 | 18.45 | 2.69 | 15823.68 |
| Cipla | 907.30 | 5.40 | 0.60 | 13900.58 |
| Dr Reddy's Labs | 4667.70 | -7.75 | -0.17 | 13349.10 |
| Sun Pharma.Inds. | 813.55 | 0.55 | 0.07 | 12803.21 |
| Lupin | 929.80 | 2.20 | 0.24 | 11055.93 |
| Apollo Hospitals | 4267.25 | 100.60 | 2.41 | 9153.00 |
| Cadila Health. | 509.00 | 10.75 | 2.16 | 7790.40 |
| Glenmark Pharma. | 507.90 | 21.80 | 4.48 | 7567.93 |
| Alkem Lab | 3698.60 | -7.60 | -0.21 | 7219.68 |
| Divi's Lab. | 5018.95 | 22.15 | 0.44 | 6798.61 |
| Torrent Pharma. | 2942.30 | -142.25 | -4.61 | 6450.83 |
| Ipca Labs. | 2188.05 | -37.25 | -1.67 | 5114.11 |
| Alembic Pharma | 756.30 | -5.55 | -0.73 | 5051.44 |
| Laurus Labs | 564.65 | 10.75 | 1.94 | 4768.72 |
| Abbott India | 20188.90 | 115.10 | 0.57 | 4310.02 |
| Gland Pharma | 3561.85 | -161.60 | -4.34 | 3462.88 |
| Glaxosmi. Pharma | 1459.15 | 5.80 | 0.40 | 3193.74 |
| Granules India | 317.75 | 2.85 | 0.91 | 3134.98 |
| Sanofi India | 8091.45 | -184.40 | -2.23 | 2901.90 |
| Ajanta Pharma | 2117.35 | -50.50 | -2.33 | 2718.59 |
Quick Links for NGL Fine Chem:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
